Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02671526 · ClinicalTrials.gov registry record · NA
Cognitive Remediation for HIV-associated Neurocognitive Dysfunction
A NA study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02671526 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 19 participants.
The verdict
NCT02671526, a NA study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study is a validation study to document the acceptability of the revised Plasticity-based Adaptive Cognitive Remediation (PACR) program to patients with HIV-associated Neurocognitive Dysfunction (HAND). The primary objective of this study is to evaluate the effects of the revised PACR program on the cognitive abilities (e.g., attention, executive function), functional status and quality of life of individuals diagnosed with HAND. The secondary objective of the study is to collect relevant data to support a pre-investigational device exemption (IDE) submission to the FDA required before the pivotal randomized, controlled trial planned for Phase II.
Interventions
- OTHER Computerized plasticity-based adaptive cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02671526
The ClinicalTrials.gov registry entry for NCT02671526 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computerized plasticity-based adaptive cognitive training is the first listed.
NCT02671526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02671526 about?
NCT02671526 is a clinical study titled "Cognitive Remediation for HIV-associated Neurocognitive Dysfunction". This study is a validation study to document the acceptability of the revised Plasticity-based Adaptive Cognitive Remediation (PACR) program to patients with HIV-associated Neurocognitive Dysfunction (HAND). The primary objective of this study is to evaluate the effects of the revised PACR program o...
What is the current status of trial NCT02671526?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2015-12. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02671526?
The interventions under investigation include: Computerized plasticity-based adaptive cognitive training (OTHER).
Who is sponsoring clinical trial NCT02671526?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.